Status:
RECRUITING
Ultrasound for Quantifying Muscle Activation Elicited by Spinal Cord Stimulation and Functional Electrical Stimulation
Lead Sponsor:
North Carolina State University
Collaborating Sponsors:
University of North Carolina, Chapel Hill
Conditions:
Neuromodulatory Effects of TSCS and FES in Lower Limbs
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Transcutaneous (non-invasive) spinal cord stimulation (tSCS) has been shown to facilitate volitional motor activity in patients with spinal cord injury. tSCS is known to activate the same neural struc...
Eligibility Criteria
Inclusion
- Between 18 and 60 years of age
- Weight less than 220 lb
- Healthy and able to walk at preferred speed without an assistive device
- Able to tolerate functional electrical stimulation and tSCS.
Exclusion
- Active infection
- history of cancer,
- broken skin, sores, or areas of acute eczema near the electrode sites
- metal implants, such as staples or pins, near the electrode sites
- any neurological disorders
- difficulty walking or an orthopedic condition that would impede walking normally without assistance
- absent sensation in the lower extremities or trunk (torso),
- allergies to adhesive skin tapes and/or ultrasound gels,
- heart conditions
- an implanted electronic device such as a pacemaker
- current pregnancy
- having no physiological response to FES and/or tSCS.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07206797
Start Date
June 1 2025
End Date
June 1 2026
Last Update
October 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Engineering Building III
Raleigh, North Carolina, United States, 27695